Blood | 2020
Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?
Nikiforow S, Mansour M, Hu Z-H, Horowitz MM, Riches M, Hematti P, Turtle CJ, Zhang M-J, Perales M-A, Pasquini MC, Frigault MJ
PubMed
PMID: 32457999
Abstract
Related Articles
CIBMTR Study #: CV20-03